Navigation Links
Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
Date:2/25/2008

MOUNTAIN VIEW, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, announced today that its Board of Directors has approved the repurchase of an aggregate of up to $40 million of its Common Stock over the next 12 months. The Company's Board of Directors decided to pursue this course of action after a review of the Company's financial position and investment alternatives. The Company expects the stock repurchase program to be accretive to earnings.

"This decision reflects our belief that our common stock is undervalued and does not reflect the intrinsic value of Omnicell, its performance and its prospects," said Randall Lipps, Chairman, President and CEO of Omnicell. "The repurchase program supports our strategic growth initiatives while utilizing available cash to optimize stockholder value. We believe Omnicell operations will continue to generate sufficient cash to make funds available for acquisitions and internal development."

Omnicell also announced that it expects 2008 earnings from operating income will be higher than previously estimated and expects the estimated return on cash investments to be reduced to an average of 3% as a result of recent Federal Reserve rate reductions, which will offset the increases in operating income. After these adjusted estimates, Omnicell reaffirms its previous 2008 earnings forecast of $0.85 to $0.88 per share, excluding stock compensation charges.

The purchases of common stock will be executed periodically as market and business conditions warrant on the open market, in negotiated or block trades, or under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company mi
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
2. Omnicell Schedules Fourth Quarter Earnings Call
3. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
4. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
5. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
6. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
7. Omnicell Reports Strong Q3 Revenue and Profit Growth
8. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
9. Omnicell Schedules Third Quarter Earnings Call
10. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
11. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 1Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 3Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 1Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 2Nuvo announces 2009 third quarter financial results 60283 1Nuvo announces 2009 third quarter financial results 60283 2Nuvo announces 2009 third quarter financial results 60283 3Nuvo announces 2009 third quarter financial results 60283 4Nuvo announces 2009 third quarter financial results 60283 5Nuvo announces 2009 third quarter financial results 60283 6Nuvo announces 2009 third quarter financial results 60283 7Nuvo announces 2009 third quarter financial results 60283 8Nuvo announces 2009 third quarter financial results 60283 9Nuvo announces 2009 third quarter financial results 60283 10Nuvo announces 2009 third quarter financial results 60283 11Nuvo announces 2009 third quarter financial results 60283 12